Skip to main content
Top
Published in: Radiation Oncology 1/2013

Open Access 01-12-2013 | Methodology

Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer

Authors: Laura Cella, Vittoria D’Avino, Raffaele Liuzzi, Manuel Conson, Francesca Doria, Adriana Faiella, Filomena Loffredo, Marco Salvatore, Roberto Pacelli

Published in: Radiation Oncology | Issue 1/2013

Login to get access

Abstract

Background

The risk of radio-induced gastrointestinal (GI) complications is affected by several factors other than the dose to the rectum such as patient characteristics, hormonal or antihypertensive therapy, and acute rectal toxicity. Purpose of this work is to study clinical and dosimetric parameters impacting on late GI toxicity after prostate external beam radiotherapy (RT) and to establish multivariate normal tissue complication probability (NTCP) model for radiation-induced GI complications.

Methods

A total of 57 men who had undergone definitive RT for prostate cancer were evaluated for GI events classified using the RTOG/EORTC scoring system. Their median age was 73 years (range 53–85). The patients were assessed for GI toxicity before, during, and periodically after RT completion. Several clinical variables along with rectum dose-volume parameters (Vx) were collected and their correlation to GI toxicity was analyzed by Spearman’s rank correlation coefficient (Rs). Multivariate logistic regression method using resampling techniques was applied to select model order and parameters for NTCP modeling. Model performance was evaluated through the area under the receiver operating characteristic curve (AUC).

Results

At a median follow-up of 30 months, 37% (21/57) patients developed G1-2 acute GI events while 33% (19/57) were diagnosed with G1-2 late GI events. An NTCP model for late mild/moderate GI toxicity based on three variables including V65 (OR = 1.03), antihypertensive and/or anticoagulant (AH/AC) drugs (OR = 0.24), and acute GI toxicity (OR = 4.3) was selected as the most predictive model (Rs = 0.47, p < 0.001; AUC = 0.79). This three-variable model outperforms the logistic model based on V65 only (Rs = 0.28, p < 0.001; AUC = 0.69).

Conclusions

We propose a logistic NTCP model for late GI toxicity considering not only rectal irradiation dose but also clinical patient-specific factors. Accordingly, the risk of G1-2 late GI increases as V65 increases, it is higher for patients experiencing previous acute toxicity and it is lower for patients who take AH/AC drugs. The developed NTCP model could represent a potentially useful tool to be used in prospective trial and for comparison among different RT techniques.
Appendix
Available only for authorised users
Literature
1.
go back to reference Michalski JM, Gay H, Jackson A, et al.: Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010,76(3 Suppl):S123-S129.CrossRefPubMedPubMedCentral Michalski JM, Gay H, Jackson A, et al.: Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010,76(3 Suppl):S123-S129.CrossRefPubMedPubMedCentral
2.
go back to reference Cella L, Lomax A, Miralbell R: New techniques in hadrontherapy: intensity modulated proton beams. Phys Med 2001,17(Suppl 1):100-102.PubMed Cella L, Lomax A, Miralbell R: New techniques in hadrontherapy: intensity modulated proton beams. Phys Med 2001,17(Suppl 1):100-102.PubMed
3.
go back to reference Cella L, Lomax A, Miralbell R: Potential role of intensity modulated proton beams in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2001,49(1):217-223. 10.1016/S0360-3016(00)01368-7CrossRefPubMed Cella L, Lomax A, Miralbell R: Potential role of intensity modulated proton beams in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2001,49(1):217-223. 10.1016/S0360-3016(00)01368-7CrossRefPubMed
4.
go back to reference Skala M, Rosewall T, Dawson L, et al.: Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2007,68(3):690-698. 10.1016/j.ijrobp.2006.12.064CrossRefPubMed Skala M, Rosewall T, Dawson L, et al.: Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2007,68(3):690-698. 10.1016/j.ijrobp.2006.12.064CrossRefPubMed
5.
go back to reference Efstathiou JA, Gray PJ, Zietman AL: Proton beam therapy and localised prostate cancer: current status and controversies. Br J Cancer 2013,108(6):1225-1230. 10.1038/bjc.2013.100CrossRefPubMedPubMedCentral Efstathiou JA, Gray PJ, Zietman AL: Proton beam therapy and localised prostate cancer: current status and controversies. Br J Cancer 2013,108(6):1225-1230. 10.1038/bjc.2013.100CrossRefPubMedPubMedCentral
6.
go back to reference Gulliford SL, Partridge M, Sydes MR, et al.: Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise. Radiother Oncol 2012,102(3):347-351. 10.1016/j.radonc.2011.10.022CrossRefPubMed Gulliford SL, Partridge M, Sydes MR, et al.: Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise. Radiother Oncol 2012,102(3):347-351. 10.1016/j.radonc.2011.10.022CrossRefPubMed
7.
go back to reference Defraene G, Van den Bergh L, Al-Mamgani A, et al.: The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2012,82(3):1233-1242. 10.1016/j.ijrobp.2011.03.056CrossRefPubMed Defraene G, Van den Bergh L, Al-Mamgani A, et al.: The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2012,82(3):1233-1242. 10.1016/j.ijrobp.2011.03.056CrossRefPubMed
8.
go back to reference Fellin G, Fiorino C, Rancati T, et al.: Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study. Radiother Oncol 2009,93(2):197-202. 10.1016/j.radonc.2009.09.004CrossRefPubMed Fellin G, Fiorino C, Rancati T, et al.: Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study. Radiother Oncol 2009,93(2):197-202. 10.1016/j.radonc.2009.09.004CrossRefPubMed
9.
go back to reference Valdagni R, Kattan MW, Rancati T, et al.: Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome. Int J Radiat Oncol Biol Phys 2012,82(5):1957-1966. 10.1016/j.ijrobp.2011.03.028CrossRefPubMed Valdagni R, Kattan MW, Rancati T, et al.: Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome. Int J Radiat Oncol Biol Phys 2012,82(5):1957-1966. 10.1016/j.ijrobp.2011.03.028CrossRefPubMed
10.
go back to reference Valdagni R, Vavassori V, Rancati T, et al.: Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial. Radiother Oncol 2012,103(2):252-255. 10.1016/j.radonc.2012.03.012CrossRefPubMed Valdagni R, Vavassori V, Rancati T, et al.: Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial. Radiother Oncol 2012,103(2):252-255. 10.1016/j.radonc.2012.03.012CrossRefPubMed
11.
go back to reference Cella L, Conson M, Caterino M, et al.: Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2012,82(5):1802-1808. 10.1016/j.ijrobp.2010.09.054CrossRefPubMed Cella L, Conson M, Caterino M, et al.: Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2012,82(5):1802-1808. 10.1016/j.ijrobp.2010.09.054CrossRefPubMed
12.
go back to reference Cella L, Liuzzi R, Conson M, et al.: Multivariate normal tissue complication probability modeling of heart valve dysfunction in hodgkin lymphoma survivors. Int J Radiat Oncol Biol Phys 2013,87(2):304-310. 10.1016/j.ijrobp.2013.05.049CrossRefPubMed Cella L, Liuzzi R, Conson M, et al.: Multivariate normal tissue complication probability modeling of heart valve dysfunction in hodgkin lymphoma survivors. Int J Radiat Oncol Biol Phys 2013,87(2):304-310. 10.1016/j.ijrobp.2013.05.049CrossRefPubMed
13.
go back to reference Cella L, Liuzzi R, Conson M, et al.: Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis. Radiat Oncol 2012, 7: 224. 10.1186/1748-717X-7-224CrossRefPubMedPubMedCentral Cella L, Liuzzi R, Conson M, et al.: Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis. Radiat Oncol 2012, 7: 224. 10.1186/1748-717X-7-224CrossRefPubMedPubMedCentral
14.
go back to reference El Naqa I, Bradley J, Blanco AI, et al.: Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys 2006,64(4):1275-1286. 10.1016/j.ijrobp.2005.11.022CrossRefPubMed El Naqa I, Bradley J, Blanco AI, et al.: Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys 2006,64(4):1275-1286. 10.1016/j.ijrobp.2005.11.022CrossRefPubMed
15.
go back to reference Fiorino C, Rancati T, Fellin G, et al.: Late fecal incontinence after high-dose radiotherapy for prostate cancer: better prediction using longitudinal definitions. Int J Radiat Oncol Biol Phys 2012,83(1):38-45. 10.1016/j.ijrobp.2011.06.1953CrossRefPubMed Fiorino C, Rancati T, Fellin G, et al.: Late fecal incontinence after high-dose radiotherapy for prostate cancer: better prediction using longitudinal definitions. Int J Radiat Oncol Biol Phys 2012,83(1):38-45. 10.1016/j.ijrobp.2011.06.1953CrossRefPubMed
16.
go back to reference El Naqa I, Suneja G, Lindsay PE, et al.: Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships. Phys Med Biol 2006,51(22):5719-5735. 10.1088/0031-9155/51/22/001CrossRefPubMed El Naqa I, Suneja G, Lindsay PE, et al.: Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships. Phys Med Biol 2006,51(22):5719-5735. 10.1088/0031-9155/51/22/001CrossRefPubMed
17.
go back to reference Gay HA, Barthold HJ, O'Meara E, et al.: Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas. Int J Radiat Oncol Biol Phys 2012,83(3):e353-e362. 10.1016/j.ijrobp.2012.01.023CrossRefPubMedPubMedCentral Gay HA, Barthold HJ, O'Meara E, et al.: Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas. Int J Radiat Oncol Biol Phys 2012,83(3):e353-e362. 10.1016/j.ijrobp.2012.01.023CrossRefPubMedPubMedCentral
18.
go back to reference Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995,31(5):1341-1346. 10.1016/0360-3016(95)00060-CCrossRefPubMed Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995,31(5):1341-1346. 10.1016/0360-3016(95)00060-CCrossRefPubMed
19.
go back to reference Pacelli R, Conson M, Cella L, et al.: Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximatedgenetic subtypes. J Radiat Res 2013,54(2):292-298. 10.1093/jrr/rrs087CrossRefPubMedPubMedCentral Pacelli R, Conson M, Cella L, et al.: Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximatedgenetic subtypes. J Radiat Res 2013,54(2):292-298. 10.1093/jrr/rrs087CrossRefPubMedPubMedCentral
20.
go back to reference Pedicini P, Caivano R, Strigari L, et al.: In regard to Miralbell et al. Re: Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: alpha/beta = 1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys 2013,85(1):10-11. 10.1016/j.ijrobp.2012.03.056CrossRefPubMed Pedicini P, Caivano R, Strigari L, et al.: In regard to Miralbell et al. Re: Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: alpha/beta = 1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys 2013,85(1):10-11. 10.1016/j.ijrobp.2012.03.056CrossRefPubMed
21.
go back to reference Pedicini P, Strigari L, Benassi M: Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys 2013,85(5):e231-7. 10.1016/j.ijrobp.2012.11.033CrossRefPubMed Pedicini P, Strigari L, Benassi M: Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys 2013,85(5):e231-7. 10.1016/j.ijrobp.2012.11.033CrossRefPubMed
22.
go back to reference Hamstra DA, Stenmark MH, Ritter T, et al.: Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2013,85(5):1246-1253. 10.1016/j.ijrobp.2012.10.042CrossRefPubMed Hamstra DA, Stenmark MH, Ritter T, et al.: Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2013,85(5):1246-1253. 10.1016/j.ijrobp.2012.10.042CrossRefPubMed
23.
go back to reference Trott KR, Doerr W, Facoetti A, et al.: Biological mechanisms of normal tissue damage: importance for the design of NTCP models. Radiother Oncol 2012,105(1):79-85. 10.1016/j.radonc.2012.05.008CrossRefPubMed Trott KR, Doerr W, Facoetti A, et al.: Biological mechanisms of normal tissue damage: importance for the design of NTCP models. Radiother Oncol 2012,105(1):79-85. 10.1016/j.radonc.2012.05.008CrossRefPubMed
24.
go back to reference van der Schaaf A, Xu CJ, van Luijk P, et al.: Multivariate modeling of complications with data driven variable selection: guarding against overfitting and effects of data set size. Radiother Oncol 2012,105(1):115-121. 10.1016/j.radonc.2011.12.006CrossRefPubMed van der Schaaf A, Xu CJ, van Luijk P, et al.: Multivariate modeling of complications with data driven variable selection: guarding against overfitting and effects of data set size. Radiother Oncol 2012,105(1):115-121. 10.1016/j.radonc.2011.12.006CrossRefPubMed
25.
go back to reference Heemsbergen WD, Peeters ST, Koper PC, et al.: Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. Int J Radiat Oncol Biol Phys 2006,66(1):3-10. 10.1016/j.ijrobp.2006.03.055CrossRefPubMed Heemsbergen WD, Peeters ST, Koper PC, et al.: Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. Int J Radiat Oncol Biol Phys 2006,66(1):3-10. 10.1016/j.ijrobp.2006.03.055CrossRefPubMed
26.
go back to reference Kharofa J, Cohen EP, Tomic R, et al.: Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int J Radiat Oncol Biol Phys 2012,84(1):238-243. 10.1016/j.ijrobp.2011.11.013CrossRefPubMed Kharofa J, Cohen EP, Tomic R, et al.: Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int J Radiat Oncol Biol Phys 2012,84(1):238-243. 10.1016/j.ijrobp.2011.11.013CrossRefPubMed
27.
go back to reference Lee TC, Greene-Schloesser D, Payne V, et al.: Chronic administration of the angiotensin-converting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment. Radiat Res 2012,178(1):46-56. 10.1667/RR2731.1CrossRefPubMedPubMedCentral Lee TC, Greene-Schloesser D, Payne V, et al.: Chronic administration of the angiotensin-converting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment. Radiat Res 2012,178(1):46-56. 10.1667/RR2731.1CrossRefPubMedPubMedCentral
28.
go back to reference Rehman A, Schiffrin EL: Vascular effects of antihypertensive drug therapy. Curr Hypertens Rep 2010,12(4):226-232. 10.1007/s11906-010-0117-3CrossRefPubMed Rehman A, Schiffrin EL: Vascular effects of antihypertensive drug therapy. Curr Hypertens Rep 2010,12(4):226-232. 10.1007/s11906-010-0117-3CrossRefPubMed
29.
go back to reference Dorr W, Hendry JH: Consequential late effects in normal tissues. Radiother Oncol 2001,61(3):223-231. 10.1016/S0167-8140(01)00429-7CrossRefPubMed Dorr W, Hendry JH: Consequential late effects in normal tissues. Radiother Oncol 2001,61(3):223-231. 10.1016/S0167-8140(01)00429-7CrossRefPubMed
30.
go back to reference Buettner F, Gulliford SL, Webb S, et al.: Using Bayesian logistic regression to evaluate a new type of dosimetric constraint for prostate radiotherapy treatment planning. Med Phys 2010,37(4):1768-1777. 10.1118/1.3367013CrossRefPubMed Buettner F, Gulliford SL, Webb S, et al.: Using Bayesian logistic regression to evaluate a new type of dosimetric constraint for prostate radiotherapy treatment planning. Med Phys 2010,37(4):1768-1777. 10.1118/1.3367013CrossRefPubMed
31.
go back to reference Valdagni R, Rancati T: Reducing rectal injury during external beam radiotherapy for prostate cancer. Nat Rev Urol 2013,10(6):345-357. 10.1038/nrurol.2013.96CrossRefPubMed Valdagni R, Rancati T: Reducing rectal injury during external beam radiotherapy for prostate cancer. Nat Rev Urol 2013,10(6):345-357. 10.1038/nrurol.2013.96CrossRefPubMed
32.
go back to reference Loeffler JS, Durante M: Charged particle therapy–optimization, challenges and future directions. Nat Rev Clin Oncol 2013,10(7):411-424. 10.1038/nrclinonc.2013.79CrossRefPubMed Loeffler JS, Durante M: Charged particle therapy–optimization, challenges and future directions. Nat Rev Clin Oncol 2013,10(7):411-424. 10.1038/nrclinonc.2013.79CrossRefPubMed
Metadata
Title
Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Authors
Laura Cella
Vittoria D’Avino
Raffaele Liuzzi
Manuel Conson
Francesca Doria
Adriana Faiella
Filomena Loffredo
Marco Salvatore
Roberto Pacelli
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2013
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-8-221

Other articles of this Issue 1/2013

Radiation Oncology 1/2013 Go to the issue